Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
Clinical trial NCT02931838 · COMPLETED
Trial details
- NCT number
- NCT02931838
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-15
- Primary completion
- 2017-11-16
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.